Malavasi F - Search Results

1

CD38 in the age of COVID-19: a medical perspective.

Horenstein AL, Faini AC, Malavasi F. Horenstein AL, et al. Among authors: malavasi f. Physiol Rev. 2021 Oct 1;101(4):1457-1486. doi: 10.1152/physrev.00046.2020. Epub 2021 Mar 31. Physiol Rev. 2021. PMID: 33787351 Free PMC article. Review.

2

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology.

Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S. Malavasi F, et al. Physiol Rev. 2008 Jul;88(3):841-86. doi: 10.1152/physrev.00035.2007. Physiol Rev. 2008. PMID: 18626062 Free article. Review.

3

CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells.

Schiavoni I, Scagnolari C, Horenstein AL, Leone P, Pierangeli A, Malavasi F, Ausiello CM, Fedele G. Schiavoni I, et al. Among authors: malavasi f. Immunology. 2018 May;154(1):122-131. doi: 10.1111/imm.12873. Epub 2017 Dec 18. Immunology. 2018. PMID: 29178427 Free PMC article.

4

CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy.

Horenstein AL, Bracci C, Morandi F, Malavasi F. Horenstein AL, et al. Among authors: malavasi f. Front Immunol. 2019 Apr 24;10:760. doi: 10.3389/fimmu.2019.00760. eCollection 2019. Front Immunol. 2019. PMID: 31068926 Free PMC article. Review.

5

The Circular Life of Human CD38: From Basic Science to Clinics and Back.

Horenstein AL, Faini AC, Morandi F, Bracci C, Lanza F, Giuliani N, Paulus A, Malavasi F. Horenstein AL, et al. Among authors: malavasi f. Molecules. 2020 Oct 21;25(20):4844. doi: 10.3390/molecules25204844. Molecules. 2020. PMID: 33096610 Free PMC article. Review.

6

Molecular dynamics of targeting CD38 in multiple myeloma.

Malavasi F, Faini AC, Morandi F, Castella B, Incarnato D, Oliviero S, Horenstein AL, Massaia M, van de Donk NWCJ, Richardson PG. Malavasi F, et al. Br J Haematol. 2021 May;193(3):581-591. doi: 10.1111/bjh.17329. Epub 2021 Feb 11. Br J Haematol. 2021. PMID: 33570193

7

[No title available]

[No authors listed] [No authors listed] PMID: 36164165

8

CD157, the Janus of CD38 but with a unique personality.

Ortolan E, Vacca P, Capobianco A, Armando E, Crivellin F, Horenstein A, Malavasi F. Ortolan E, et al. Among authors: malavasi f. Cell Biochem Funct. 2002 Dec;20(4):309-22. doi: 10.1002/cbf.978. Cell Biochem Funct. 2002. PMID: 12415565 Review.

9

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.

Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L, Boumsell L, Malavasi F. Deaglio S, et al. Among authors: malavasi f. Blood. 2005 Apr 15;105(8):3042-50. doi: 10.1182/blood-2004-10-3873. Epub 2004 Dec 21. Blood. 2005. PMID: 15613544 Free article.

10

CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.

Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, Tibaldi EV, Durelli I, Lusso R, Cozno F, Horenstein AL. Malavasi F, et al. Mol Med. 2006 Nov-Dec;12(11-12):334-41. doi: 10.2119/2006–00094.Malavasi. Mol Med. 2006. PMID: 17380201 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page